Clinical Trials Browser

Phase 2 × NETWORK × larotrectinib × Clear all

NCT03834961 2025-12-02

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Phase 2 Active not recruiting

33 enrolled 18 charts

Central Nervous System Neoplasms